Compounds and methods for treatment of thromboembolic disorders
CA 2071145 A1 · Owner: Eli Lilly And Company · Inventors: Burck, Philip J.; Zimmerman, Ronald E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
X-7878, Abstract, The present invention provides adducts of human t-PA derivatives, wherein said adducts comprise a t-PA derivative that lacks the Finger, Growth Factor and Kringle 1 domains, bound to an amphipathic molecule. The invention also provides methods for preparing said adducts and compositions for the treatment of thromboembolic disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 12, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 12, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 12, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.